| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.44 | 0.01 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |